Nordion announces cash consideration increase to $13 per share from Sterigenics
MLex Summary: NYSE-listed health science company Nordion said Monday that Sterigenics has increased its cash consideration to acquire all the issued and outstanding common shares of Nordion to $13 per share from $12.25 per share. The deal...To view the full article, register now.
Already a subscriber? Click here to view full article